Utilidad de hemoglobina glicosilada en diabetes tipo 2

Abstract

Diabetes is one of the major global health problems around the world. There are three main types of diabetes: type 1 diabetes, type 2 diabetes and gestational diabetes. Among the types of diabetes, type 2 diabetes is the most common, accounting for about 85% to 90% of all cases. It is also the most dangerous because its lack of signs and symptoms make its diagnosis to be made, generally, when any of its complications have appeared. One of the main tests used to measure the average level of glucose or sugar in the blood is Glycosylated Hemoglobin (HbA1c). The main objective of this study is to capture what is related to the uses of HbA1c in patients with type 2 diabetes. The research model was documentary or bibliographic. Among the results of the usefulness of HbA1c, it was found that it is used as a diagnostic test for the states of dysglycemia and diabetes, in combination with other diabetes tests such as fasting blood glucose and the glucose tolerance test (PTG). Likewise, in the control of type 2 diabetics, it is the main tool that allows adequate management and adjustment of treatment. Lastly, it is an important predictor of complications associated with type 2 diabetes. In conclusion, HbA1c is currently the test of choice for the follow-up and chronic treatment of diabetes, especially type 2 diabetes, from a diagnostic point of view, it remains somewhat controversial. The versatility of its uses, its use as a great tool in the prevention, diagnosis, treatment, control and prognosis of complications in patients with type 2 diabetes.

Púrpura oral no trombocitopénica en paciente diabético: Reporte de caso

“…(13). En efecto, el caso reportado demostró pobre control metabólico sustentado en el valor aumentado de la hemoglobina glicosilada e IgA sérica (14,15). Paralelamente, el nivel de PCR detectado en la paciente es categorizado en la literatura científica como riesgo cardiovascular moderado (16), sugiriendo inflamación sistémica de bajo grado; estado fundamentado, además, en el compromiso periodontal (4,(17)(18)(19).…”

Nursing intervention in the care of patients with diabetes mellitus

“…In this type of diabetes, the body's immune system attacks and destroys the insulin-producing cells in the pancreas leading to an absolute deficiency of insulin. People with type 1 diabetes require daily insulin injections to control their blood glucose levels (Poveda et al, 2020).…”

“…More than 90% of all diabetics in the United States belong to this group. In type 2 diabetes, normal or elevated blood insulin levels are sufficient to prevent ketoacidosis, but insufficient to prevent hyperglycemia (Campos, Ovares y Arens, 2020) (Poveda et al, 2020).…”

Hemoglobina glicosilada como indicador de control glicémico en pacientes con diabetes mellitus tipo 2 del Laboratorio Clínico Chiriguaya, Daule

“…Los datos epidemiológicos indican que la diabetes se encuentra en niveles críticos y con tendencia al aumento. Cada siete segundos, muere alguna persona que la padece (Coello et al, 2020;Poveda et al, 2020). Las estadísticas muestran que 463 millones de personas entre las edades de 20 y 79 años tienen diabetes.…”

“…Flores y cols. (Flores et al, 2020) en el año 2020 en Ecuador-Guayaquil, mediante su trabajo investigativo titulado Utilidad de hemoglobina glicosilada en diabetes tipo 2, la metodología aplicada fue de tipo documental y el propósito fue plasmar lo referente a los usos de la HbA1c en pacientes con DM2. Dentro de los hallazgos se encontró que la HbA1c es una prueba esencial para el diagnóstico de los estados de disglucemia y diabetes, asimismo, en el control de los pacientes con diabetes tipo 2 considerándose como la principal herramienta que permite el correcto control y ajuste de tratamiento.…”